These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22658525)

  • 1. Effects of polypharmacy on sleep in psychiatric inpatients.
    Waters F; Faulkner D; Naik N; Rock D
    Schizophr Res; 2012 Aug; 139(1-3):225-8. PubMed ID: 22658525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of medications and diagnoses on fall risk in psychiatric inpatients.
    Lavsa SM; Fabian TJ; Saul MI; Corman SL; Coley KC
    Am J Health Syst Pharm; 2010 Aug; 67(15):1274-80. PubMed ID: 20651318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual impairment in psychiatric inpatients: focus on depression.
    Cohen S; Kühn KU; Bender S; Erfurth A; Gastpar M; Murafi A; Rothermundt M; Signerski J; Sträter B; Teusch L; Weig W; Welling A; Westheide J; Huber TJ
    Pharmacopsychiatry; 2007 Mar; 40(2):58-63. PubMed ID: 17447174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of psychiatric medications on sleep and sleep disorders.
    DeMartinis NA; Winokur A
    CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):17-29. PubMed ID: 17305551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.
    Pogge DL; Young K; Insalaco B; Harvey PD
    Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.
    Procyshyn RM; Su J; Elbe D; Liu AY; Panenka WJ; Davidson J; Honer WG; Barr AM
    J Clin Psychopharmacol; 2014 Feb; 34(1):17-22. PubMed ID: 24346744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic treatment of children with anti-NMDAR encephalitis.
    Mohammad SS; Jones H; Hong M; Nosadini M; Sharpe C; Pillai SC; Brilot F; Dale RC
    Dev Med Child Neurol; 2016 Apr; 58(4):376-84. PubMed ID: 26330176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
    Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders associated with disturbed sleep.
    Krahn LE
    Semin Neurol; 2005 Mar; 25(1):90-6. PubMed ID: 15798941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drugs for the treatment of sleep disturbances--neuroleptics and antidepressants].
    Adler L
    Z Arztl Fortbild Qualitatssich; 2001 Jan; 95(1):27-31. PubMed ID: 11233490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Feb; 25(2):65-71. PubMed ID: 2417773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medication history of inpatient adolescents--is there a rationale for benzodiazepine prescription?
    Ilomäki R; Ilomäki E; Hakko H; Räsänen P
    Addict Behav; 2011; 36(1-2):161-5. PubMed ID: 21035951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.
    Gisev N; Bell JS; Chen TF
    Int J Clin Pract; 2014 Feb; 68(2):236-44. PubMed ID: 24372715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.